Menu

• Ask a Health Expert about VITREOUS OPACITIES
• Post Your Side Effect related to VITREOUS OPACITIES
• VITREOUS OPACITIES and FDA Warnings
• VITREOUS OPACITIES in Patients Wiki
• Report VITREOUS OPACITIES in Drug Side Effect Survey

VITREOUS OPACITIES side effect

What is VITREOUS OPACITIES ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Avastin Side Effects Report #5498368-0
Health Professional from UNITED KINGDOM reported AVASTIN problem on July 16, 2007. Female patient, 74 years of age, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: vitreous opacities, vitritis, . AVASTIN dosage: 0.04 ML, UNK. Patient recovered.

Atacand Side Effects Report #5390218-6
ATACAND HCT problem was reported by a Consumer or non-health professional from GERMANY on July 09, 2007. Female patient was diagnosed with hypertension and was treated with ATACAND HCT. After drug was administered, patient experienced the following problems/side effects: vitreous opacities, . ATACAND HCT dosage: 16/12.5 MG DAILY. During the same period patient was treated with ATACAND HCT. Patient recovered.

Atacand Side Effects Report #5390218-6
Consumer or non-health professional from GERMANY reported ATACAND HCT problem on July 09, 2007. Female patient was diagnosed with hypertension and was treated with ATACAND HCT. After drug was administered, patient experienced the following problems/side effects: vitreous opacities, . ATACAND HCT dosage: 16/12.5 MG DAILY. During the same period patient was treated with ATACAND HCT. Patient recovered.

Atacand Side Effects Report #5415800-9
ATACAND HCT problem was reported by a Physician from GERMANY on Aug 09, 2007. Female patient, weighting 156.5 lb, was diagnosed with hypertension and was treated with ATACAND HCT. After drug was administered, patient experienced the following problems/side effects: vitreous detachment, vitreous opacities, . ATACAND HCT dosage: 16/12.5 MG DAILY. During the same period patient was treated with ATACAND HCT. Patient recovered.


Lyrica Side Effects Report #5481024-2
Physician from GERMANY reported LYRICA problem on Sept 27, 2007. Male patient, weighting 255.7 lb, was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: vision blurred, visual field defect, vitreous opacities, . LYRICA dosage: unknown. During the same period patient was treated with NEURONTIN, IBUPROFEN. Patient recovered.

Lucentis Side Effects Report #5503496-7
LUCENTIS problem was reported by a Physician from SWITZERLAND on Oct 17, 2007. Male patient, 75 years of age, was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: eye inflammation, visual acuity reduced, vitreous opacities, . LUCENTIS dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVE AGENTS. Patient was hospitalized. Patient recovered.

Lansoprazole Side Effects Report #5347010-8
Consumer or non-health professional from GERMANY reported LANSOPRAZOLE problem on Feb 05, 2007. Male patient, 73 years of age, was diagnosed with stomach discomfort and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: headache, vision blurred, vitreous opacities, . LANSOPRAZOLE dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID, UBRETID, OMNIC OCAS. Patient recovered.